Skip to main content

Center for Technology Transfer and Commercialization Archives

Three teams take top prizes at inaugural innovation challenge

Jun. 8, 2017—Last week, Vanderbilt’s Department of Radiology and Radiological Sciences hosted the inaugural RadX Innovation Challenge Pitch Event.

Read more


VU-invented wireless ECG system receives FDA approval

Oct. 22, 2015—A wireless electrocardiogram (ECG) system invented at Vanderbilt University and marketed by a Nashville company, InvisionHeart, has received U.S. Food and Drug Administration (FDA) approval.

Read more


Collaboration seeks to develop new therapies for bone, other diseases

Oct. 1, 2015—La Jolla Pharmaceutical Co. and Vanderbilt University have signed a research and license agreement covering Vanderbilt’s research program and intellectual property rights related to compounds that block bone morphogenetic protein (BMP) type-I receptors. The compounds have therapeutic potential in a broad range of diseases, including rare genetic disorders.

Read more


‘Challenge’ puts technology transfer ingenuity on display

Apr. 16, 2015—A strategy for commercializing a potential new test for colon cancer that can make tumor cells “glow” won top honors at last week’s TechVenture Challenge.

Read more


VU’s technology transfer efforts gain steam

Jul. 24, 2014—Vanderbilt University signed 101 licensing agreements with industry partners in fiscal year 2014, nearly 20 more than the record total set last year.

Read more


New system helps speed transfer of research materials

Mar. 20, 2014—Vanderbilt University Medical Center has launched an automated system for processing and managing Material Transfer Agreements (MTAs), which govern the transfer of biological materials, chemicals, human tissue samples and other materials between institutions to facilitate academic research.

Read more


VU’s technology commercialization efforts make strides

Sep. 26, 2013—Over the past three years, Vanderbilt University more than quadrupled earnings from its technology commercialization efforts — to more than $24.5 million in the 2013 fiscal year that ended June 30, officials have announced.

Read more


Technology transfer efforts bolstered by recent agreements

Mar. 28, 2013—Last month, Vanderbilt University announced a collaboration agreement with GlaxoSmithKline, a leading pharmaceutical and consumer health care company, to develop potential new drugs for severe obesity.

Read more


Kudos

Jun. 2, 2011—Read about Vanderbilt faculty, staff, student and alumni's latest awards, appointments and achievements

Read more


Bentley named assistant vice chancellor for Center for Technology Transfer and Commercialization

Apr. 28, 2011—Alan Bentley, director of Commercialization for Cleveland Clinic Innovations with the Cleveland Clinic Foundation, has been named assistant vice chancellor of Technology Transfer and Intellectual Property Development.

Read more


Recent Stories from VUMC News and Communications Publications

The first few minutes of Charlie’s life were a blur, as a team of doctors and nurses at VUMC worked to resuscitate him and stabilize his heart rate. He was then transferred to the Neonatal Intensive Care Unit at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Hope

The first few minutes of Charlie’s life were a blur, as a team of doctors and nurses at VUMC worked to resuscitate him and stabilize his heart rate. He was then transferred to the Neonatal Intensive Care Unit at Monroe Carell Jr. Children’s Hospital at Vanderbilt.

Tucked away in a Vanderbilt conference room, 36 adults huddle over Lego pieces. Eleven teams have been assigned to assemble multicolored Legos using the written directions included in the packet. The result should be a Frankenstein figure.

Vanderbilt Nurse

Tucked away in a Vanderbilt conference room, 36 adults huddle over Lego pieces. Eleven teams have been assigned to assemble multicolored Legos using the written directions included in the packet. The result should be a Frankenstein figure.

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

Vanderbilt Medicine

Marissa Benchea has CF, and she is one of hundreds of thousands of adults not only surviving but thriving with a chronic childhood disease.

One hundred years ago, multiple “waves” of a deadly flu swept across the world.

Vanderbilt Medicine

One hundred years ago, multiple “waves” of a deadly flu swept across the world.

more